Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities    
Net loss $ (22,224) $ (20,948)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 11,680 15,290
Stock-based compensation 8,241 8,533
Foreign currency transaction loss 531 2,792
Share in losses of associated companies 2,425 75
Revaluation of investments 1,042 1,061
Other non-cash items, net (95) 83
Change in cash attributable to changes in operating assets and liabilities:    
Accounts receivable, net 1,081 (7,950)
Inventories (10,123) (14,775)
Other current assets and prepaid expenses 2,945 7,386
Other non-current assets 2,746 (85)
Accounts payable (18,547) 7,194
Other current liabilities 1,622 (16,037)
Deferred revenues 3,387 2,522
Deferred income taxes, net and uncertain tax positions 2,581 (381)
Other non-current liabilities (5,218) (823)
Net cash used in operating activities (17,926) (16,063)
Cash flows from investing activities    
Cash paid for acquisitions, net of cash acquired (16,480)  
Purchase of property and equipment (3,723) (3,741)
Investments in short-term bank deposits (12,448) (40,000)
Proceeds from short-term bank deposits 111,367 117,000
Purchase of intangible assets (311) (444)
Other investing activities (30) (47)
Investments in unconsolidated entities (2,453) (5,030)
Net cash provided by investing activities 75,922 67,738
Cash flows from financing activities    
Proceeds from exercise of stock options 4 155
Other financing activities 851 866
Net cash provided by financing activities 855 1,021
Effect of exchange rate changes on cash, cash equivalents and restricted cash (168) (2,228)
Net change in cash, cash equivalents and restricted cash 58,683 50,468
Cash, cash equivalents and restricted cash, beginning of period 150,686 243,293
Cash, cash equivalents and restricted cash, end of period 209,369 293,761
Supplemental disclosures of cash flow information:    
Transfer of inventory to fixed assets 3,604 188
Transfer of fixed assets to inventory 97 120
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:    
Cash and cash equivalents 209,139 293,649
Restricted cash included in other current assets 230 112
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows $ 209,369 $ 293,761